Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: Results from the SEARCH Database

Journal of Urology

Volumn 169, Issue 6, 2003, Pages 2129-2135

  Freedland, Stephen J ^a   Presti Jr , Joseph C ^b   Terris, Martha K ^b   Kane, Christopher J ^b   Aronson, William J ^b   Dorey, Frederick ^b   Amling, Christopher L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Biopsy; Neoplasm staging; Prostate; Prostatic neoplasms; Recurrence

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; PALPATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SEMINAL VESICLE; TREATMENT OUTCOME;

EID: 0037950113     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000065763.21602.14     Document Type: Article

References (24)

1. Beahrs, O. H., Henson, D. E. and Hutter, R. V. P.: American Joint Committee on Cancer Staging Manual. Philadelphia: Lippincott, 1992
2. Fleming, I. D., Cooper, J. S., Henson, D. E., Hutter, R. P. V., Kennedy, B. J., Murphy, G. P. et al: American Joint Committee on Cancer Staging Manual. Philadelphia: Lippincott, p. 219, 1997
3. Cagiannos, I., Graefen, M., Karakiewicz, P. I., Ohori, M., Eastham, J. A., Rabbani, F. et al: Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement? J Clin Oncol, 20: 2025, 2002
4. Han, M., Walsh, P. C., Partin, A. W. and Rodriguez, R.: Ability of the 1992 and 1997 American Joint Committee on Cancer staging systems for prostate cancer to predict progression-free survival after radical prostatectomy for stage T2 disease. J Urol, 164: 89, 2000
5. May, F., Hartung, R. and Breul, J.: The ability of the American Joint Committee on Cancer Staging system to predict progression-free survival after radical prostatectomy. BJU Int, 88: 702, 2001
6. Catalona, W. J., Ramos, C. G. and Carvalhal, G. F.: Contemporary results of anatomic radical prostatectomy. CA Cancer J Clin, 49: 282, 1999
7. Ghavamian, R., Blute, M. L., Bergstralh, E. J., Slezak, J. and Zincke, H.: Comparison of clinically nonpalpable prostatespecific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy. Urology, 54: 105, 1999
8. Kattan, M. W., Eastham, J. A., Stapleton, A. M., Wheeler, T. M. and Scardino, P. T.: A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst, 90: 766, 1998
9. Ramos, C. G., Carvalhal, G. F., Smith, D. S., Mager, D. E. and Catalona, W. J.: Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer. J Urol, 161: 1525, 1999
10. Lerner, S. E., Blute, M. L. and Zincke, H.: Risk factors for progression in patients with prostate cancer treated with radical prostatectomy. Semin Urol Oncol, 14: 12, 1996
11. Moul, J. W., Connelly, R. R., Lubeck, D. P., Bauer, J. J., Sun, L., Flanders, S. C. et al: Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases. J Urol, 166: 1322, 2001
12. Freedland, S. J., Amling, C. L., Dorey, F., Kane, C. J., Presti, J. C., Jr., Terris, M. K. et al: Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database. Urology, 60: 670, 2002
13. Campbell, T., Blasko, J., Crawford, E. D., Forman, J., Hanks, G., Kuban, D. et al: Clinical staging of prostate cancer: reproducibility and clarification of issues. Int J Cancer, 96: 198, 2001
14. Jager, G. J., Barentz, J. O., Ruijter, E. T., de la Rosette, J. J. and Oosterhof, G. O.: Primary staging of prostate cancer. Eur Radiol, 6: 134, 1996
15. Bostwick, D. G.: Staging prostate cancer - 1997: current methods and limitations. Eur Urol, 32: 2, 1997
16. Hull, G. W., Rabbani, F., Abbas, F., Wheeler, T. M., Kattan, M. W. and Scardino, P. T.: Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol, 167: 528, 2002
17. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Blank, K., Broderick, G. A. et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA, 280: 969, 1998
18. Liebross, R. H., Pollack, A., Lankford, S. P., von Eschenbach, A. C. and Zagars, G. K.: Relationship of ultrasound staging and bilateral biopsy positivity to outcome in stage T1c prostate cancer treated with radiotherapy. Urology, 52: 647, 1998
19. Daniels, G. F., Jr., McNeal, J. E. and Stamey, T. A.: Predictive value of contralateral biopsies in unilaterally palpable prostate cancer. J Urol, 147: 870, 1992
20. Obek, C., Louis, P., Civantos, F. and Soloway, M. S.: Comparison of digital rectal examination and biopsy results with the radical prostatectomy specimen. J Urol, 161: 494, 1999
21. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Fondurulia, J., Chen, M. H. et al: Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol, 18: 1164, 2000
22. Freedland, S. J., Csathy, G. S., Dorey, F. and Aronson, W. J.: Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol, 167: 516, 2002
23. Horwitz, E. M., Vicini, F. A., Ziaja, E. L., Dmuchowski, C. F., Stromberg, J. S. and Martinez, A. A.: The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology. Int J Radiat Oncol Biol Phys, 41: 267, 1998
24. Pound, C. R., Partin, A. W., Eisenberger, M. A., Chan, D. W., Pearson, J. D. and Walsh, P. C.: Natural history of progression after PSA elevation following radical prostatectomy. JAMA, 281: 1591, 1999